Skip to main content
Journal of Experimental Orthopaedics

Table 3 90-day Medical Complications Following THA in HRT Users vs. Control

From: Hormone replacement therapy does not increase thrombosis risk following THA: a national database study

 

HRT

(n = 3936)

Control

(n = 39,360)

OR

95% CI

P

DVT

52

1.32%

554

1.41%

0.94

0.70—1.25

0.6601

PE

15

0.38%

187

0.48%

0.80

0.47—1.36

0.4102

Transfusion

141

3.58%

1333

3.39%

1.06

0.89—1.26

0.5188

UTI

147

3.73%

1655

4.20%

0.88

0.74—1.04

0.1595

Pneumonia

32

0.81%

403

1.02%

0.79

0.55—1.14

0.207

AKI

35

0.89%

344

0.87%

1.02

0.72—1.44

0.922

  1. Rates of 90-day medical complications were compared between cohorts using odds ratios and 95% confidence intervals
Back to article page